Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide Cagri+Sema powder with 99 purity
Cagrilintide Cagri+Sema powder with 99 purity buy - large image1
Cagrilintide Cagri+Sema powder with 99 purity buy - image1
Cagrilintide Cagri+Sema powder with 99 purity buy - image2
Cagrilintide Cagri+Sema powder with 99 purity buy - image3
Cagrilintide Cagri+Sema powder with 99 purity buy - image4
Cagrilintide Cagri+Sema powder with 99 purity buy - image5
Cagrilintide Cagri+Sema powder with 99 purity buy - image6

Cagrilintide Cagri+Sema powder with 99 purity

TDS 51 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

focuses

Packaging:

as requires

Price valid (until):

2025-05-09

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    China Lab Customization Cagrilintide Cagri Lyophilized Powder Weight Loss Peptide

    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 1

    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 2



    Items Specifications
    Product Name: Cagrilintide Shop High Pure Raw Powder S Emaglutide peptide powder CAS 91 0463-68-2 at Best Price-Detailed Image 3
    Synonyms: Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate
    CAS: 1415456-99-3
    Form  Solid
    Color  White to off-white
    Description
    Cagrilintide is under development for the treatment of obesity and type 2 diabetes. The drug candidate is administered as a once-daily and once-weekly subcutaneous formulation. It is a long-acting amylin analogue. Amylin is co-located with insu in secretory granules and co-secreted with insu by pancreatic beta cells in response to food intake.

    Application
    Weight loss 
    Anti-diabetes
    Alzheimer's disease





    Our Factory

    Fujian Genohope Biotech Ltd was established in 2019, It was co-founded by New Hope  Hosencare Brothers  and Taiwan Genovior Biotech Corporation. The company is located in the national "Cross-Strait Biotechnology and Health and Medical Industry Cooperation Zone" in Putian City, Fujian Province. The company has 260 employees, and in 2023, the company was selected as a Specialized in special innovative enterprises in Fujian Province.

    The company focuses on High potency polypeptide API/solution, and sells polypeptide API/solution and preparation production services to the global market. The company covers a total area of 55 mu, with a total construction area of about 70,000 square meters, and has built about 800 square meters of R & D center, 1,000 square meters of  quality control center and 3,300 square meters of GMP production workshop. At present, 13 production  lines have been built, including 7 production lines for the preparation of recombinant peptide API and fully synthetic peptide API and 6 lines for injections. In addition, the company also has a large anti-tumor injection workshop, a small multi-purpose injection workshop, a large multi-purpose injection workshop. The construction and operation management of the production line meet the regulatory requirements of the global drug market and meet the double registration and declaration of China and the United States. Also can meet the customer registration and sales at home and abroad.

    Product superiority:

    At present, the company's main products are Semaglutide, Tirzepatide, Retatrutide, cosmetic medicine microspheres, collagen. In particular, the company has the advantage of mature 2 processes preparation of Semaglutide API, Semaglutide API registered in the US FDA (DMF No. : 040957),Tirzepatide API registered in the US FDA (DMF No. : 040503),

    Semaglutide API has the following three characteristics: low price, high quality, and large production capacity (tonnage). Tirzepatide API is well received favourable reviews in the pharmaceutical industry of polypeptide .

    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 6


    Our Certificate


    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 7 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 8 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 9 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 10
    Shop 99 Purity Peptides Powder Liraglutide CAS 204656-20-2-Detailed Image 10
    FAQ

    Q: What does semaglutide do to your body?

    A: Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy.

    Q: What is the dark side of semaglutide?

    A: Pancreatitis (swelling of the pancreas) may occur while you are using this medicine. Check with your doctor right away if you have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.

    Q: Who cannot take semaglutide?

    A: Thyroid cancer or if someone in your family had thyroid cancer. An unusual or allergic reaction to semaglutide, other medications, foods, dyes, or preservatives. Pregnant or trying to get pregnant. Breast-feeding.

    Q: Why do I feel so bad on semaglutide?

    A: However, semaglutide also affects the gastrointestinal tract by increasing the amount of glucagon. This has two effects on the digestive tract. First, it slows down the movement of food through your gut, which can lead to nausea, vomiting, and diarrhea.

    Q: Can semaglutide be harmful?

    A: Nausea, vomiting, and diarrhea are the most common semaglutide side effects. But they usually subside after a few weeks of using the medication. Although rare, serious side effects are possible. Some may require immediate medical attention, such as pancreatitis and allergic reactions.

    Q: Can semaglutide damage your pancreas?

    A: Does Semaglutide Damage Your Pancreas? Semaglutide has been associated with pancreatitis, which is an inflammation of the pancreas. While pancreatitis can cause damage to the pancreas, the occurrence of this side effect due to semaglutide is considered uncommon.

    Q: Can I lose 50 lbs on semaglutide?

    A: According to clinical trials, people on a weekly semaglutide dosage can expect to lose an average of 5–10% of their body weight. Patients who were overweight lost 5.9% of their body weight after three months of weekly semaglutide injections. The average weight loss was 10.9% after 6 months of weekly injections.

    Q: Is metformin as good as semaglutide?

    A: Between these two medications, semaglutide produces more significant weight loss than metformin, but metformin tends to be a more affordable option. But patients can also opt to combine these drugs to maximize their effects with a proper treatment plan.

    Certificates
    • Cagrilintide Cagri+Sema powder with 99 purity Certificates 1

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

    Location:

    NO.288,Renyang, Binglun Village, Hushi Town, Xiuyu DistrictPutian City, Fujian Province 351146, China (CHN)

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    2

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    201-300

    Year of Establishment:

    2019

    Certifications:

    DMF ACKNOWLEDGEMENT,Notice of GMP Compliance Inspection

    Company Profile

    Fujian Genohope Biotech Ltd., is founded by New Hope Group, a Fortune Global 500 company, together with Genovior, fomous Taiwan peptide company and now a member of the Polaris Pharma Group, as the globalized center for R&D and production of peptide products, located in the National Biotech and Health Industry Zone of Across-Strait in Putian City, Fujian Province.

    The company focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.

    In 2023, Genehope has been rewarded as Specialized and Novel Enterprise of Fujian Province.
    In 2023 June, the US FDA completed its first on-site inspection for Genohope.

  • Inquiry History
    51 Inquiries
    Country Product Purchase Quantity Date Posted
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    India

    Cagrilintide

    1 KG Apr 13, 2026
    United States

    Tirzepatide

    50 MT Apr 2, 2026
    India

    CAGRILINTIDE

    100 MG Mar 11, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.